Request for Covid-19 Impact Assessment of this Report
The United States Tasigna market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tasigna market, reaching US$ million by the year 2028. As for the Europe Tasigna landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tasigna players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tasigna market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
50mg
200mg
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drugs Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tasigna Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tasigna by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tasigna by Country/Region, 2017, 2022 & 2028
2.2 Tasigna Segment by Type
2.2.1 50mg
2.2.2 200mg
2.2.3 Other
2.3 Tasigna Sales by Type
2.3.1 Global Tasigna Sales Market Share by Type (2017-2022)
2.3.2 Global Tasigna Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tasigna Sale Price by Type (2017-2022)
2.4 Tasigna Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Tasigna Sales by Application
2.5.1 Global Tasigna Sale Market Share by Application (2017-2022)
2.5.2 Global Tasigna Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tasigna Sale Price by Application (2017-2022)
3 Global Tasigna by Company
3.1 Global Tasigna Breakdown Data by Company
3.1.1 Global Tasigna Annual Sales by Company (2020-2022)
3.1.2 Global Tasigna Sales Market Share by Company (2020-2022)
3.2 Global Tasigna Annual Revenue by Company (2020-2022)
3.2.1 Global Tasigna Revenue by Company (2020-2022)
3.2.2 Global Tasigna Revenue Market Share by Company (2020-2022)
3.3 Global Tasigna Sale Price by Company
3.4 Key Manufacturers Tasigna Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tasigna Product Location Distribution
3.4.2 Players Tasigna Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tasigna by Geographic Region
4.1 World Historic Tasigna Market Size by Geographic Region (2017-2022)
4.1.1 Global Tasigna Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tasigna Annual Revenue by Geographic Region
4.2 World Historic Tasigna Market Size by Country/Region (2017-2022)
4.2.1 Global Tasigna Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tasigna Annual Revenue by Country/Region
4.3 Americas Tasigna Sales Growth
4.4 APAC Tasigna Sales Growth
4.5 Europe Tasigna Sales Growth
4.6 Middle East & Africa Tasigna Sales Growth
5 Americas
5.1 Americas Tasigna Sales by Country
5.1.1 Americas Tasigna Sales by Country (2017-2022)
5.1.2 Americas Tasigna Revenue by Country (2017-2022)
5.2 Americas Tasigna Sales by Type
5.3 Americas Tasigna Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tasigna Sales by Region
6.1.1 APAC Tasigna Sales by Region (2017-2022)
6.1.2 APAC Tasigna Revenue by Region (2017-2022)
6.2 APAC Tasigna Sales by Type
6.3 APAC Tasigna Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tasigna by Country
7.1.1 Europe Tasigna Sales by Country (2017-2022)
7.1.2 Europe Tasigna Revenue by Country (2017-2022)
7.2 Europe Tasigna Sales by Type
7.3 Europe Tasigna Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tasigna by Country
8.1.1 Middle East & Africa Tasigna Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tasigna Revenue by Country (2017-2022)
8.2 Middle East & Africa Tasigna Sales by Type
8.3 Middle East & Africa Tasigna Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tasigna
10.3 Manufacturing Process Analysis of Tasigna
10.4 Industry Chain Structure of Tasigna
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tasigna Distributors
11.3 Tasigna Customer
12 World Forecast Review for Tasigna by Geographic Region
12.1 Global Tasigna Market Size Forecast by Region
12.1.1 Global Tasigna Forecast by Region (2023-2028)
12.1.2 Global Tasigna Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tasigna Forecast by Type
12.7 Global Tasigna Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Tasigna Product Offered
13.1.3 Novartis Tasigna Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Tasigna Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tasigna Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 200mg
Table 5. Major Players of Other
Table 6. Global Tasigna Sales by Type (2017-2022) & (MT)
Table 7. Global Tasigna Sales Market Share by Type (2017-2022)
Table 8. Global Tasigna Revenue by Type (2017-2022) & ($ million)
Table 9. Global Tasigna Revenue Market Share by Type (2017-2022)
Table 10. Global Tasigna Sale Price by Type (2017-2022) & (USD/Kg)
Table 11. Global Tasigna Sales by Application (2017-2022) & (MT)
Table 12. Global Tasigna Sales Market Share by Application (2017-2022)
Table 13. Global Tasigna Revenue by Application (2017-2022)
Table 14. Global Tasigna Revenue Market Share by Application (2017-2022)
Table 15. Global Tasigna Sale Price by Application (2017-2022) & (USD/Kg)
Table 16. Global Tasigna Sales by Company (2020-2022) & (MT)
Table 17. Global Tasigna Sales Market Share by Company (2020-2022)
Table 18. Global Tasigna Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Tasigna Revenue Market Share by Company (2020-2022)
Table 20. Global Tasigna Sale Price by Company (2020-2022) & (USD/Kg)
Table 21. Key Manufacturers Tasigna Producing Area Distribution and Sales Area
Table 22. Players Tasigna Products Offered
Table 23. Tasigna Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Tasigna Sales by Geographic Region (2017-2022) & (MT)
Table 27. Global Tasigna Sales Market Share Geographic Region (2017-2022)
Table 28. Global Tasigna Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Tasigna Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Tasigna Sales by Country/Region (2017-2022) & (MT)
Table 31. Global Tasigna Sales Market Share by Country/Region (2017-2022)
Table 32. Global Tasigna Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Tasigna Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Tasigna Sales by Country (2017-2022) & (MT)
Table 35. Americas Tasigna Sales Market Share by Country (2017-2022)
Table 36. Americas Tasigna Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Tasigna Revenue Market Share by Country (2017-2022)
Table 38. Americas Tasigna Sales by Type (2017-2022) & (MT)
Table 39. Americas Tasigna Sales Market Share by Type (2017-2022)
Table 40. Americas Tasigna Sales by Application (2017-2022) & (MT)
Table 41. Americas Tasigna Sales Market Share by Application (2017-2022)
Table 42. APAC Tasigna Sales by Region (2017-2022) & (MT)
Table 43. APAC Tasigna Sales Market Share by Region (2017-2022)
Table 44. APAC Tasigna Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Tasigna Revenue Market Share by Region (2017-2022)
Table 46. APAC Tasigna Sales by Type (2017-2022) & (MT)
Table 47. APAC Tasigna Sales Market Share by Type (2017-2022)
Table 48. APAC Tasigna Sales by Application (2017-2022) & (MT)
Table 49. APAC Tasigna Sales Market Share by Application (2017-2022)
Table 50. Europe Tasigna Sales by Country (2017-2022) & (MT)
Table 51. Europe Tasigna Sales Market Share by Country (2017-2022)
Table 52. Europe Tasigna Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Tasigna Revenue Market Share by Country (2017-2022)
Table 54. Europe Tasigna Sales by Type (2017-2022) & (MT)
Table 55. Europe Tasigna Sales Market Share by Type (2017-2022)
Table 56. Europe Tasigna Sales by Application (2017-2022) & (MT)
Table 57. Europe Tasigna Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Tasigna Sales by Country (2017-2022) & (MT)
Table 59. Middle East & Africa Tasigna Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Tasigna Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Tasigna Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Tasigna Sales by Type (2017-2022) & (MT)
Table 63. Middle East & Africa Tasigna Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Tasigna Sales by Application (2017-2022) & (MT)
Table 65. Middle East & Africa Tasigna Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Tasigna
Table 67. Key Market Challenges & Risks of Tasigna
Table 68. Key Industry Trends of Tasigna
Table 69. Tasigna Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Tasigna Distributors List
Table 72. Tasigna Customer List
Table 73. Global Tasigna Sales Forecast by Region (2023-2028) & (MT)
Table 74. Global Tasigna Sales Market Forecast by Region
Table 75. Global Tasigna Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Tasigna Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Tasigna Sales Forecast by Country (2023-2028) & (MT)
Table 78. Americas Tasigna Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Tasigna Sales Forecast by Region (2023-2028) & (MT)
Table 80. APAC Tasigna Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Tasigna Sales Forecast by Country (2023-2028) & (MT)
Table 82. Europe Tasigna Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Tasigna Sales Forecast by Country (2023-2028) & (MT)
Table 84. Middle East & Africa Tasigna Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Tasigna Sales Forecast by Type (2023-2028) & (MT)
Table 86. Global Tasigna Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Tasigna Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Tasigna Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Tasigna Sales Forecast by Application (2023-2028) & (MT)
Table 90. Global Tasigna Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Tasigna Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Tasigna Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novartis Basic Information, Tasigna Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Tasigna Product Offered
Table 95. Novartis Tasigna Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
List of Figures
Figure 1. Picture of Tasigna
Figure 2. Tasigna Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tasigna Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Tasigna Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tasigna Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 200mg
Figure 11. Product Picture of Other
Figure 12. Global Tasigna Sales Market Share by Type in 2021
Figure 13. Global Tasigna Revenue Market Share by Type (2017-2022)
Figure 14. Tasigna Consumed in Hospital
Figure 15. Global Tasigna Market: Hospital (2017-2022) & (MT)
Figure 16. Tasigna Consumed in Drugs Store
Figure 17. Global Tasigna Market: Drugs Store (2017-2022) & (MT)
Figure 18. Tasigna Consumed in Other
Figure 19. Global Tasigna Market: Other (2017-2022) & (MT)
Figure 20. Global Tasigna Sales Market Share by Application (2017-2022)
Figure 21. Global Tasigna Revenue Market Share by Application in 2021
Figure 22. Tasigna Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Tasigna Revenue Market Share by Company in 2021
Figure 24. Global Tasigna Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Tasigna Revenue Market Share by Geographic Region in 2021
Figure 26. Global Tasigna Sales Market Share by Region (2017-2022)
Figure 27. Global Tasigna Revenue Market Share by Country/Region in 2021
Figure 28. Americas Tasigna Sales 2017-2022 (MT)
Figure 29. Americas Tasigna Revenue 2017-2022 ($ Millions)
Figure 30. APAC Tasigna Sales 2017-2022 (MT)
Figure 31. APAC Tasigna Revenue 2017-2022 ($ Millions)
Figure 32. Europe Tasigna Sales 2017-2022 (MT)
Figure 33. Europe Tasigna Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Tasigna Sales 2017-2022 (MT)
Figure 35. Middle East & Africa Tasigna Revenue 2017-2022 ($ Millions)
Figure 36. Americas Tasigna Sales Market Share by Country in 2021
Figure 37. Americas Tasigna Revenue Market Share by Country in 2021
Figure 38. United States Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Tasigna Sales Market Share by Region in 2021
Figure 43. APAC Tasigna Revenue Market Share by Regions in 2021
Figure 44. China Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Tasigna Sales Market Share by Country in 2021
Figure 51. Europe Tasigna Revenue Market Share by Country in 2021
Figure 52. Germany Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Tasigna Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Tasigna Revenue Market Share by Country in 2021
Figure 59. Egypt Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Tasigna Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Tasigna in 2021
Figure 65. Manufacturing Process Analysis of Tasigna
Figure 66. Industry Chain Structure of Tasigna
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...